Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer

Wake Forest University (WFU)

Status: Terminated

Conditions: Endometrial Cancer

Treatments: Other: Surveys

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05877404

P30CA012197 (U.S. NIH Grant/Contract)

IRB00097221

NCI-2023-05554 (Other Identifier)

WFBCCC 99323

Details and patient eligibility

About

In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.

Full description

Primary Objective: Proportion of physicians reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients.

Secondary Objectives:

• Explore the use of informed consent in tumor genetic testing in endometrial cancer
• Explore clinician confidence in utilizing tumor genetic testing to guide treatment decisions.
• Explore the impact of recent publications regarding immunotherapy on the use of tumor genetic testing in endometrial cancer.

Enrollment: 112 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Member of the Society of Gynecologic Oncology
• Gynecologic Oncologist or Gynecologic Oncology Fellow-in-Training

Trial design

112 participants in 1 patient group

Gynecologic Oncologists

Description:

Gynecologic Oncologists and gynecologic oncology fellows-in-training from around the world, who are members of the Society of Gynecologic Oncology (SGO).

Treatment:

Other: Surveys